Mr. Nunes is responsible for all market development activities related to the OMNINAV robotic total joint replacement surgery.
Here are four things to know about Mr. Nunes:
• He has more than 30 years of sales and marketing management experience at emerging growth medical device companies.
• He was senior vice president of sales and marketing at MAKO Surgical.
• Sales and marketing efforts he led grew MAKO revenue from $0.5 million to $85 million in four years.
• The position was created for Mr. Nunes.
“I was attracted to OMNI because I was particularly looking forward to expanding the growth of ONMINAV, the only FDA cleared surgical robotic system designed to enhance the surgeon’s implant placement for total knee replacements,” Mr. Nunes said. “After more than 4,500 procedures in the U.S., I believe OMNI’s robotic technology is positioned to deliver the significant value to patients, surgeons, hospitals and all other stakeholders in the healthcare system.”
More articles on orthopedic devices:
17 spine devices receive FDA 510(k) clearance in December
Amedica restructuring includes 28% staff reduction, new spine focus—5 key points
Bacterin revenue up for 5th consecutive quarter—5 things to know
